Viking Therapeutics

Yahoo Finance • 16 hours ago

Viking Therapeutics Inc (VKTX) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Rising ...

Research and Development Expenses: $41.4 million for Q1 2025, up from $24.1 million in Q1 2024. General and Administrative Expenses: $14.1 million for Q1 2025, up from $10 million in Q1 2024. Net Loss: $45.6 million or $0.41 per share for... Full story

Yahoo Finance • 7 days ago

Eli Lilly Soars as Oral Diabetes Pill Hits Targets in Phase 3

Eli Lilly (NYSE:LLY) shares surged around 14% in premarket trading Thursday after the company reported positive Phase 3 trial results for orforglipron, its once-daily oral GLP-1 drug for type 2 diabetes. Warning! GuruFocus has detected 6... Full story

Yahoo Finance • 7 days ago

2 Stocks Down by 25% or More This Year to Buy and Hold

Equity markets have had a rough go of it this year due to President Trump's macroeconomic policies. Though it can be challenging to navigate this environment, one way to make the best of it is to look for terrific stocks to invest in while... Full story

Yahoo Finance • 9 days ago

Down 71%, Should You Buy the Dip on Viking Therapeutics Stock?

No one ever claimed investing in the biotech industry was a smooth ride, but for shareholders of Viking Therapeutics(NASDAQ: VKTX), the turbulence has been extremely challenging thus far. The stock is down 71% over the past year, amid ongo... Full story

Yahoo Finance • 10 days ago

Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today

Bad news for Pfizer (NYSE: PFE) turned into good news for Eli Lilly (NYSE: LLY), Novo Nordisk(NYSE: NVO), and Viking Therapeutics(NASDAQ: VKTX) Monday morning, each of which is rising on Pfizer's latest product announcement. Early this mo... Full story

Yahoo Finance • 12 days ago

3 Magnificent Stocks That Could Double or More by 2030

When the stock market is as turbulent as it is these days, it's easy to forget the times when things are decidedly more cheery. However, sell-offs present great opportunities to buy stocks with significant upside potential. Three Motley F... Full story

Yahoo Finance • last month

Why Viking Therapeutics Inc. (VKTX) Is Skyrocketing Today?

We recently published a list of 10 Stocks Skyrocketing Today. In this article, we are going to take a look at where Viking Therapeutics Inc. (NASDAQ:VKTX) stands against other stocks that are skyrocketing today. The stock market ended mix... Full story

Yahoo Finance • 2 months ago

AbbVie Enters The Obesity Arena. Why It's Paying Up To $2.23 Billion.

AbbVie inked a licensing deal Monday worth up to $2.23 billion for an amylin-targeting obesity treatment from Denmark-based Gubra A/S. Continue Reading View Comments... Full story

Yahoo Finance • 2 months ago

Why Viking Therapeutics, Inc. (VKTX) Went Up On Wednesday?

We recently published a list of 10 Stocks Stand Strong Amid Cautious Market Environment. In this article, we are going to take a look at where Viking Therapeutics, Inc. (NASDAQ:VKTX) stands against stocks that stand strong amid cautious ma... Full story

Yahoo Finance • 3 months ago

Viking Therapeutics, Inc. (VKTX): One of January’s Biggest Losers

We recently published a list of 15 Stocks That Took a Nosedive in January. In this article, we are going to take a look at where Viking Therapeutics, Inc. (NASDAQ:VKTX) stands against other stocks that took a nosedive in January. Historic... Full story

Yahoo Finance • 3 months ago

Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.

Biotech stocks are poised for an exciting 2025 as experts watch for new weight-loss drugs, AI's impact and Trump's second presidency. Continue reading View comments... Full story

Yahoo Finance • 6 months ago

Madrigal Catapults After Novo's Wegovy Proves It's No 'Silver Bullet' In MASH

Madrigal stock catapulted again Friday after Novo Nordisk published not "game-changing" results for its MASH treatment. Continue reading View comments... Full story

Yahoo Finance • 7 months ago

Is Viking Therapeutics Inc. (VKTX) the Best Performing Small-Cap Stock in 2024?

We recently compiled a list of the 10 Best Performing Small-Cap Stocks in 2024. In this article, we will look at where Viking Therapeutics Inc. (NASDAQ:VKTX) ranks among the best-performing small-cap stocks in 2024. The Case for Small Cap... Full story

Yahoo Finance • 8 months ago

Prediction: This Biotech Stock Will Outperform Nvidia in the Second Half of the Year

Nvidia(NASDAQ: NVDA) is a tough one to beat when it comes to share-price performance. The technology giant has seen its shares soar 2,500% over the past five years, and this year, it's heading for a 118% increase. There's a good reason fo... Full story

Yahoo Finance • 8 months ago

Viking Therapeutics (VKTX) Fell Amid Rising Competition

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here. Small-cap stocks were unable to sustain the po... Full story

Yahoo Finance • 8 months ago

Viking Therapeutics Stock Could Rocket 76% Higher According to Wall Street. Is It a Buy Now?

Shares of Viking Therapeutics(NASDAQ: VKTX), a clinical-stage drugmaker working on metabolic treatments, have tripled in value this year. Despite the huge run-up, analysts who follow the company think it has heaps more upside. The average... Full story

Yahoo Finance • 8 months ago

Director J Singleton Sells 16,000 Shares of Viking Therapeutics Inc (VKTX)

On August 19, 2024, J Singleton, Director at Viking Therapeutics Inc (NASDAQ:VKTX), executed a sale of 16,000 shares of the company. The transaction was documented in a recent SEC Filing. Following this transaction, the insider now owns 9,... Full story

Yahoo Finance • 8 months ago

Why Is Viking Therapeutics, Inc. (VKTX) the Best Diabetes Stock to Buy Now?

We recently compiled a list of the 7 Best Diabetes Stocks To Buy Now.In this article, we are going to take a look at where Viking Therapeutics, Inc. (NASDAQ:VKTX) stands against the other diabetes stocks. According to the WHO, approximate... Full story

Yahoo Finance • 9 months ago

The Bull Case for Viking Therapeutics Just Got Even Stronger. Here's Why You Should Buy It.

Viking Therapeutics(NASDAQ: VKTX) just gave shareholders a few more reasons to be excited for the future. With its shares soaring by a stunning 34% on July 25 thanks to second-quarter earnings, the bull thesis for its continued outperforma... Full story

Yahoo Finance • 9 months ago

Attention, Growth Investors: This Biotech Stock Is Crushing Nvidia.

If you're an investor focused on growth, you may have spent a fair share of your time at least watching Nvidia (NASDAQ: NVDA) stock in recent times -- even if you haven't jumped in to invest in this high-flyer. Nvidia dominates the artific... Full story